Perlmutter Cancer Center at NYU Langone Hospital ae Long Island — New York, New York

Perlmutter Cancer Center at NYU Langone Hospital ae Long Island is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center at NYU Langone Hospital ae Long Island has participated in 1 clinical trials.

Therapeutic areas: Head and Neck Cancer.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center at NYU Langone Hospital ae Long Island?

Perlmutter Cancer Center at NYU Langone Hospital ae Long Island has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center at NYU Langone Hospital ae Long Island conducted?

Perlmutter Cancer Center at NYU Langone Hospital ae Long Island has 1 clinical trials on record. Their work covers Head and Neck Cancer.

Is Perlmutter Cancer Center at NYU Langone Hospital ae Long Island accredited by Crixeo Health?

Perlmutter Cancer Center at NYU Langone Hospital ae Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Center at NYU Langone Hospital ae Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.